Climb Bio CLYM
NASDAQ CLYM
$10.96 +0.16 (+1.48%)
As of: Oct 21, 2026 · 1:40 PM EDT

Climb Bio (CLYM) EV to CFO (2024)

Updated

Climb Bio's (CLYM) EV to CFO was -129.03 for Q2 2024.

Analysis

Climb Bio (CLYM) EV to CFO (2024) Analysis & Trends

Over the twelve months ended Jun 30, 2024, Climb Bio's EV to CFO came in at -5730.12.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.99 Bn 1,102.58 Bn 19.71 Bn
2 Johnson & Johnson 615.70 Bn 534.23 Bn 17.26 Bn
3 AbbVie 501.05 Bn 474.16 Bn 12.70 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.20 Bn 234.88 Bn 12.86 Bn
7 Amgen 235.55 Bn 190.95 Bn 7.24 Bn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn
9 Pfizer 169.29 Bn 115.93 Bn 10.94 Bn
10 Climb Bio 834.65 Mn 353.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -129.03
API Access

Climb Bio EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=CLYM&period=max&api_key=YOUR_API_KEY